These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6315398)

  • 61. Effect of calcium antagonist drugs on calcium currents in mammalian skeletal muscle fibers.
    Walsh KB; Bryant SH; Schwartz A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):403-7. PubMed ID: 2418195
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
    Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.
    Bellemann P; Schade A; Towart R
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2356-60. PubMed ID: 6300912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels.
    Schwartz LM; McCleskey EW; Almers W
    Nature; 1985 Apr 25-May 1; 314(6013):747-51. PubMed ID: 2581141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.
    Spedding M
    Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules.
    Curtis BM; Catterall WA
    Biochemistry; 1986 Jun; 25(11):3077-83. PubMed ID: 2425846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle.
    Catterall WA; Seagar MJ; Takahashi M
    J Biol Chem; 1988 Mar; 263(8):3535-8. PubMed ID: 2450086
    [No Abstract]   [Full Text] [Related]  

  • 71. Receptor pharmacology of calcium entry blocking agents.
    Vaghy PL; Williams JS; Schwartz A
    Am J Cardiol; 1987 Jan; 59(2):9A-17A. PubMed ID: 2433927
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The devapamil-binding site of the purified skeletal muscle receptor for organic-calcium channel blockers is modulated by micromolar and millimolar concentrations of Ca2+.
    Schneider T; Regulla S; Hofmann F
    Eur J Biochem; 1991 Aug; 200(1):245-53. PubMed ID: 1652439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reconstitution of the purified receptor for calcium channel blockers.
    Sieber M; Nastainczyk W; Röhrkasten A; Hofmann F
    Biomed Biochim Acta; 1987; 46(8-9):S357-62. PubMed ID: 2829861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry.
    Batra S
    Br J Pharmacol; 1985 Aug; 85(4):767-74. PubMed ID: 2412621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells.
    Shalom R; Barki-Harrington L; Rimon G
    Eur J Pharmacol; 2006 Aug; 543(1-3):8-13. PubMed ID: 16842773
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.